Effects of flavonoids extracted from the whole plant of Patrinia Villosa (Thunb) Juss in a rat model of chronic pelvic inflammation
Purpose: To investigate the effects of total flavonoids (PLV) extracted from the whole plant of Patrinia Villosa (Thunb.) Juss (PTJ) in a rat model of chronic pelvic inflammation.
Methods: An orthogonal test design was employed to optimize the extraction conditions of PLV via reflux extraction by ethanol. Rats were randomly divided into control group, model group and PLV groups. An absorbable gelatin sponge with pathogens was inserted into the cervix of the rat to establish a pelvic inflammatory model. The PLV groups were orally administered PLV at doses of 25, 50 and 100 mg/kg for eight days. Enzyme-linked immunosorbent assay (ELISA) was used for the determination of inflammatory cytokines in rat serum and the culture supernatant of RAW264.7 cells. Real-time reverse transcription polymerase chain reaction (real-time PCR) was employed to determine mRNA levels.
Results: The optimum extraction conditions for PLV by orthogonal test were obtained: extraction time (120 min), ratio of liquid to raw material (20 mL/g) and ethanol concentration (50 %). By treating with PLV, the levels of TNF-α, IL-6 and IL-1β significantly decreased (p < 0.01), while IL-10 level significantly increased (p < 0.01) in the serum of chronic pelvic inflammatory rats and LPS-stimulated macrophages. In addition, a similar trend was observed in the mRNA levels of LPS-stimulated macrophages treated with PLV.
Conclusion: PLV showes significant anti-inflammatory effects on chronic pelvic inflammation. The potential mechanism is related to regulating the expression of inflammatory factors
Keywords: Patrinia Villosa (Thunb.) Juss, Total flavonoids, Chronic pelvic inflammation, Inflammatory cytokines
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.